Find the Achilles’ Heel: Sitting Down With Amy Jensen-Smith
October 12, 2026
SOTIO Biotech’s CSO explains why drug developers should test their weakest assumptions early, how she builds innovative teams, and where ADCs could go next
8 min read
False
Advertisement
Latest
Prula-cel Shows Early Promise in Lupus
October 8, 2026
Adicet Bio reports 12-month remission and renal response data for its allogeneic gamma delta CAR T therapy
2 min read
The Staying Power of Small Molecules
October 8, 2026
We asked the 2026 Power List whether newer modalities have eclipsed small molecules – and where the traditional mainstay still wins
4 min read
Video: Sitting Down With… John Tomtishen
October 7, 2026
Catalent’s John Tomtishen discusses his path into cell therapy and the evolving approaches to CMC, manufacturing, and commercialization
1 min read
Pregnancy After CAR T Shows Early Promise
By Mouj Hijazi
October 7, 2026
No autoimmune disease flares occurred across 14 pregnancies after CAR T-cell therapy, with 8 healthy babies born and 5 pregnancies ongoing.
3 min read
When CAR T Cells Linger in the Gut
By Mouj Hijazi
October 7, 2026
Persistent CAR T cells and widespread immune disruption may help explain a rare form of severe intestinal inflammation after BCMA-directed therapy
3 min read
Building a Pre-Disease Data Map
October 7, 2026
Mayo Clinic and Thermo Fisher launch a large-scale multi-omics resource designed to reveal disease before symptoms appear
2 min read
Building a CAR-T CMC Strategy on a Limited Budget
By Kate Fynes
October 6, 2026
Early developers do not need a finalized commercial process before first-in-human studies, but they do need a clear plan for managing cost, scalability, comparability, and future manufacturing changes
7 min read
Musings from The Power List: Andres Sirulnik
By Andres Sirulnik
October 5, 2026
Regeneron's L. Andres Sirulnik explains why modernizing clinical trials is as important as developing new medicines
4 min read
Video: From Accounting to Action on Pharma Sustainability
October 2, 2026
Ahead of CPHI Milan’s Sustainability Summit, Silvia Forroova and Rob Williams discuss how shared standards and supplier partnerships can turn commitments into measurable progress.
1 min read
